Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Urszula L McClurg

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Oncotarget|May 13, 2015
Deubiquitinating enzymes as oncotargetsUrszula L McClurg, Craig N Robson
Oncotarget|September 13, 2014
Deubiquitinating enzyme Usp12 regulates the interaction between the androgen receptor and the Akt pathwayUrszula L McClurg, Emma E Summerscales, Victoria J Harle, et al.
Microbes and Infection|December 16, 2014
Epithelial cell ADAM17 activation by Helicobacter pylori: role of ADAM17 C-terminus and Threonine-735 phosphorylationUrszula L McClurg, Kazuma Danjo, Harry O King, et al.
BMC Medicine|May 18, 2017
ING3 promotes prostate cancer growth by activating the androgen receptorArash Nabbi, Urszula L McClurg, Subhash Thalappilly, et al.
Oncotarget|June 5, 2018
The novel anti-androgen candidate galeterone targets deubiquitinating enzymes, USP12 and USP46, to control prostate cancer growth and survivalUrszula L McClurg, Mahsa Azizyan, Daniel T Dransfield, et al.
Oncotarget|October 13, 2016
Nutlin-3 inhibits androgen receptor-driven c-FLIP expression, resulting in apoptosis of prostate cancer cellsIan R Logan, Urszula L McClurg, Dominic L Jones, et al.
Oncotarget|October 14, 2015
Ubiquitin-specific protease 12 interacting partners Uaf-1 and WDR20 are potential therapeutic targets in prostate cancerUrszula L McClurg, Victoria J Harle, Arash Nabbi, et al.
Genome Research|February 17, 2026
A systematic guide for identifying transcription factors that directly regulate the expression of a gene of interestAndrew D Bates, Dawid Grzela, Maciej Studzian, et al.
Communications Biology|December 9, 2021
Centrosome dysfunction associated with somatic expression of the synaptonemal complex protein TEX12Sumit Sandhu, Ieng F Sou, Jill E Hunter, et al.
Oncogene|May 15, 2018
Molecular mechanism of the TP53-MDM2-AR-AKT signalling network regulation by USP12Urszula L McClurg, Nay C T H Chit, Mahsa Azizyan, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Oncotarget|May 13, 2015
Deubiquitinating enzymes as oncotargetsUrszula L McClurg, Craig N Robson
Oncotarget|September 13, 2014
Deubiquitinating enzyme Usp12 regulates the interaction between the androgen receptor and the Akt pathwayUrszula L McClurg, Emma E Summerscales, Victoria J Harle, et al.
Microbes and Infection|December 16, 2014
Epithelial cell ADAM17 activation by Helicobacter pylori: role of ADAM17 C-terminus and Threonine-735 phosphorylationUrszula L McClurg, Kazuma Danjo, Harry O King, et al.
BMC Medicine|May 18, 2017
ING3 promotes prostate cancer growth by activating the androgen receptorArash Nabbi, Urszula L McClurg, Subhash Thalappilly, et al.
Oncotarget|June 5, 2018
The novel anti-androgen candidate galeterone targets deubiquitinating enzymes, USP12 and USP46, to control prostate cancer growth and survivalUrszula L McClurg, Mahsa Azizyan, Daniel T Dransfield, et al.
Oncotarget|October 13, 2016
Nutlin-3 inhibits androgen receptor-driven c-FLIP expression, resulting in apoptosis of prostate cancer cellsIan R Logan, Urszula L McClurg, Dominic L Jones, et al.
Oncotarget|October 14, 2015
Ubiquitin-specific protease 12 interacting partners Uaf-1 and WDR20 are potential therapeutic targets in prostate cancerUrszula L McClurg, Victoria J Harle, Arash Nabbi, et al.
Genome Research|February 17, 2026
A systematic guide for identifying transcription factors that directly regulate the expression of a gene of interestAndrew D Bates, Dawid Grzela, Maciej Studzian, et al.
Communications Biology|December 9, 2021
Centrosome dysfunction associated with somatic expression of the synaptonemal complex protein TEX12Sumit Sandhu, Ieng F Sou, Jill E Hunter, et al.
Oncogene|May 15, 2018
Molecular mechanism of the TP53-MDM2-AR-AKT signalling network regulation by USP12Urszula L McClurg, Nay C T H Chit, Mahsa Azizyan, et al.
Pageof 2